[Federal Register Volume 83, Number 140 (Friday, July 20, 2018)]
[Notices]
[Pages 34589-34590]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15526]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-18-1091]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Using Qualitative Methods to Understand 
Issues in HIV Prevention, Care and Treatment in the United States'' to 
the Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on March 13, 2018 to obtain 
comments from the public and affected agencies. CDC received four 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to <a href="/cdn-cgi/l/email-protection#7916141b391a1d1a571e160f"><span class="__cf_email__" data-cfemail="3a5557587a595e59145d554c">[email protected]</span></a>. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Using Qualitative Methods to Understand Issues in HIV Prevention, 
Care and Treatment in the United States (OMB No. 0920-1091; expires 
December 31, 2018)--Extension--National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention, Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The CDC's National Center on HIV/AIDS, Viral Hepatitis, STD and TB 
Prevention (NCHHSTP), Division of HIV/AIDS Prevention (DHAP) seeks a 
three year extension for an existing Generic information collection 
request (Generic ICR) entitled, ``Using Qualitative Methods to 
Understand Issues in HIV Prevention, Care and Treatment in the United 
States'' (OMB Number: 0920-1091). Specific studies conducted under this 
extended Generic ICR will be consistent with the national HIV 
prevention goals, the CDC Division of HIV/AIDS Prevention (DHAP) 
Strategic Plan, and DHAP's High-impact HIV Prevention approach.
    The purposes for each data collection study supported under this 
extended Generic ICR will be to understand specific barriers and 
facilitators to local HIV prevention, care and treatment in the United 
States and territories. For example, each study will seek to identify 
ways to improve programmatic activities along the continuum of HIV 
prevention, treatment and care for different populations residing in 
different geographic settings with greatest burden of HIV.
    The target populations for studies included in this extended 
Generic ICR include, but are not limited to: Persons living with HIV 
who are in treatment; persons living with HIV who are out of treatment 
and who may or may not be seeking treatment at healthcare facilities; 
persons at high risk for HIV acquisition (HIV negative) and HIV 
transmission (HIV positive); persons from groups at high risk for HIV 
including gay, bisexual and other MSM, transgender persons, and 
injection and non-injection drug users; persons from racial and ethnic 
minorities; and healthcare providers or other professionals who provide 
HIV prevention, care and treatment services. Other populations may 
include individuals who provide non-HIV services or otherwise interact 
with persons living with HIV or persons at risk for HIV acquisition.
    Studies will only provide local contextual information about the 
barriers and facilitators to HIV prevention, care, and treatment 
experienced by specific communities at risk for acquiring HIV 
infection, by HIV-positive persons across the HIV care continuum, and 
by organizations or individuals providing HIV prevention, care, 
treatment, and related support services.
    Data collection methods used in any of the specific studies 
primarily will consist of rapid qualitative assessment methodologies, 
such as semi-structured and in-depth qualitative interviews, focus 
groups; direct observations; document reviews; and short structured 
surveys. Data will be analyzed using

[[Page 34590]]

well-established qualitative analysis methods, such as coding 
interviews for themes about barriers and successes to HIV prevention, 
care, and treatment. Structured response surveys will be analyzed using 
descriptive statistics and other appropriate statistical methods.
    CDC will use the results from each specific data collection study 
to help to identify ways to improve local programmatic activities for 
specific communities along the continuum of HIV prevention, treatment 
and care for populations and areas with the greatest HIV burden. CDC 
will communicate study outcomes to local stakeholders and organizations 
in positions to consider and implement site-specific improvements in 
HIV prevention, care, and treatment for each of the study sites 
examined. For stakeholders, organizations, or agencies outside the 
local affected communities, all communications will include clear 
discussion of the limitations of the region-specific, qualitative 
methods and the non-generalizability of the study outcomes.
    For a given year, each separate data collection will range from 30 
(minimum) to 200 (maximum) respondents based on the nature and scope of 
the research purposes. For example, if there are three data 
collections, the maximum combined number of expected respondents is 
600. In a given year, CDC anticipates that the need to screen 1600 
persons to identify 800 eligible persons, of which 600 persons will 
agree to participate.
    CDC anticipates that screener forms will take five minutes to 
complete each, contact information forms will take one minute to 
complete each, and consent forms will take five minutes to complete 
each. CDC anticipates 50% of the targeted populations screened will be 
eligible for the study. Of eligible persons, 75% will agree to 
participate.
    Brief structured surveys will take 15 minutes to complete. In-depth 
interviews or focus groups with respondents are expected to take 60 
minutes (one hour) to complete. In-depth interviews or focus groups 
with healthcare providers are expected to take 45 minutes to complete.
    The total annual response burden based on an average of 600 study 
respondents per year (assuming three large data collections involving 
200 participants each) is estimated at 918 hours. There is no cost to 
respondents other than their time.

----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
General Public--Adults................  Study Screener..........            1600               1            5/60
General Public--Adults................  Contact Information Form             600               1            1/60
General Public--Adults................  Consent Form............             600               1            5/60
General Public--Adults................  Demographic Survey......             500               1           15/60
General Public--Adults................  Interview Guide.........             500               1               1
General Public--Adults................  Provider Demographic                 100               1           15/60
                                         Survey.
General Public--Adults................  Provider Interview Guide             100               1           45/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of 
Scientific Integrity, Office of the Associate Director for Science, 
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-15526 Filed 7-19-18; 8:45 am]
 BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>